APA (7th ed.) Citation

C, S., JL, F., P, M., D, S., RJ, W., SB, G., . . . JG, K. (2026). Controlled human infection with Mycobacterium tuberculosis: Practical considerations for clinical trials. The Lancet. Microbe, 7(3), 101278. https://doi.org/10.1016/j.lanmic.2025.101278

Chicago Style (17th ed.) Citation

C, Seshadri, et al. "Controlled Human Infection with Mycobacterium Tuberculosis: Practical Considerations for Clinical Trials." The Lancet. Microbe 7, no. 3 (2026): 101278. https://doi.org/10.1016/j.lanmic.2025.101278.

MLA (9th ed.) Citation

C, Seshadri, et al. "Controlled Human Infection with Mycobacterium Tuberculosis: Practical Considerations for Clinical Trials." The Lancet. Microbe, vol. 7, no. 3, 2026, p. 101278, https://doi.org/10.1016/j.lanmic.2025.101278.